Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Unicycive Therapeutics Inc (NQ: UNCY )

0.4900 -0.0124 (-2.47%)
Streaming Delayed Price Updated: 3:59 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 104,514
Open 0.5074
Bid (Size) 0.4900 (32)
Ask (Size) 0.5299 (2)
Prev. Close 0.5024
Today's Range 0.4900 - 0.5194
52wk Range 0.4004 - 2.870
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
The 7 Most Undervalued Penny Stocks to Buy in October 2023
Undervalued penny stocks offer tremendous return for investors with an appetite for risk but these shares are relatively safe as well. 
Via InvestorPlace

Performance

YTD
-2.02%
-2.02%
1 Month
-12.50%
-12.50%
3 Month
-38.75%
-38.75%
6 Month
-64.75%
-64.75%
1 Year
-32.43%
-32.43%

More News

Read More
Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Where Unicycive Therapeutics Stands With Analysts
Via Benzinga
Analyst Expectations for Unicycive Therapeutics's Future
Via Benzinga
Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
CORRECTION FROM SOURCE: 60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
Via ACCESSWIRE
60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
Via ACCESSWIRE
Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Conference
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
What 7 Analyst Ratings Have To Say About Unicycive Therapeutics
Via Benzinga
Unicycive Therapeutics Announces Publication of Positive Comparison of Oxylanthanum Carbonate to Commercially Available Phosphate Binders in the American Journal of Nephrology
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Nasdaq Jumps 200 Points; Baudax Bio Shares Spike Higher
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Crude Oil Rises Over 1%; Fed's Preferred Inflation Gauge Slows In May
Via Benzinga
Why Is Enphase Energy (ENPH) Stock Up Today?
Via InvestorPlace
XPEV Stock Alert: Xpeng’s SUV Pricing Beats Out Tesla’s Model Y
Via InvestorPlace
Why Is Unicycive Therapeutics (UNCY) Down 24% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Are Unicycive Therapeutics Shares Trading Lower Today
Via Benzinga
Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Unicycive Therapeutics Provides Regulatory Update on Lanthanum Dioxycarbonate Program
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Unicycive to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.